0001562180-22-003585.txt : 20220429
0001562180-22-003585.hdr.sgml : 20220429
20220429210019
ACCESSION NUMBER: 0001562180-22-003585
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220428
FILED AS OF DATE: 20220429
DATE AS OF CHANGE: 20220429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUGIN ROBERT J
CENTRAL INDEX KEY: 0001232505
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 22878766
MAIL ADDRESS:
STREET 1: C/O THE MEDICINES CO
STREET 2: 8 CAMPUS DR
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-04-28
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001232505
HUGIN ROBERT J
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
true
false
false
false
Stock Option (Right to Buy)
97.74
2022-04-28
4
A
false
8239.00
0.00
A
2032-04-27
Common Shares
8239.00
8239.00
D
The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2023 or (b) the date of the 2023 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date.
/s/ George Clark, Attorney-in-Fact
2022-04-29